Limin: The 10,000 t/a Glufosinate-P and 1,000 t/a Glufosinate ammonium technical transformation project was approved

On September 18, Limin announced that Hebei Weiyuan, a wholly-owned subsidiary of the company, received the "Reply to the Environmental Impact Report on the technical transformation of Weiyuan with 10,000 t/a Glufosinate-P and the construction project with an annual output of 1,000 t/a Glufosinate ammonium(Phase I)" issued by the Circulation Chemical Park Branch of the Shijiazhuang Hi-Tech Industrial Development Zone (Phase I) 

The approval approved Weiyuan Biochemical in the existing plant, the construction of 1,000 t/a Glufosinate ammonium technical transformation and 10,000 t/a Glufosinate-P construction project. After the EIA approval is obtained, Weiyuan Biochemical, a wholly-owned subsidiary of Limin Shares, will carry out the project construction in a timely manner according to the company's plans and arrangements, in accordance with the EIA approval and the requirements of relevant laws and regulations.